072-366-1366
主な国際論文
| 著者名、論文タイトル、掲載雑誌名、発行年、掲載ページの順です。 一部の論文は無料で閲覧が可能です。 |
|
| 1 | Kino H, Hama J, Takenaka T, Sugimura K, Kamoi K, Shimada S, Yamamoto Y, Nagata S, Kai T, Horiuchi M, Katori R. Effect of an angiotensin II receptor antagonist, TCV-116, on neointimal formation following balloon injury in the SHR carotid artery. Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S360-2. |
| 2 | Kai T, Shimada S, Kurooka A, Takenaka T, Ishikawa K. Tissue angiotensin II concentration in the heart and kidneys in transgenic Tsukuba hypertensive mice. Blood Press. 1998 Jan;7(1):61-3. |
| 3 | Kai T, Kino H, Ishikawa K. Role of the renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in transgenic hypertensive mice carrying both human renin and angiotensinogen genes. Hypertens Res. 1998 Mar;21(1):39-46. |
| 4 | Kai T, Kino H, Sugimura K, Shimada S, Kurooka A, Akamatsu K, Takenaka T, Fukamizu A, Murakami K, Ishikawa K, Katori R. Significant role of the increase inrenin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in double transgenic tsukuba hypertensive mice carrying both human renin and angiotensinogen genes. Clin Exp Hypertens. 1998 May;20(4):439-49. |
| 5 | Kai T, Sugimura K, Shimada S, Kurooka A, Takenaka T, Ishikawa K. Inhibitory effects of a subdepressor dose of L-158,809, an angiotensin II type 1 receptor antagonist, on cardiac hypertrophy and nephropathy via the activated human renin-angiotensin system in double transgenic mice with hypertension. Jpn Circ J. 1998 Aug;62(8):599-603. |
| 6 | Kai T, Sugimura K, Shimada S, Kurooka A, Takenaka T, Ishikawa K. Enhanced angiotensin II stimulates renal disorders in transgenic Tsukuba hypertensive mice. Blood Press. 1998 Jul;7(4):247-50. |
| 7 | Kai T, Shimada S, Sugimura K, Kurooka A, Takenaka T, Fukamizu A, Murakami K, Ishikawa K. Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice. J Hypertens. 1998 Dec;16(12 Pt 2):2045-9. |
| 8 | Kai T, Sugimura K, Shimada S, Kurooka A, Ishikawa K. Renin-angiotensin system stimulates cardiac and renal disorders in Tsukuba hypertensive mice. Clin Exp Pharmacol Physiol. 1999 Mar;26(3):206-11. |
| 9 | Kai T, Sugimura K, Kino H, Takenaka T, Shimada S, Kurooka A, Ishikawa K. Effect of Lisinopril on deposition of iron in renal tissue in Tsukuba hypertensive mice carrying human renin-angiotensin system genes. Nephrology 2000 May;5(2):105-8. |
| 10 | Kai T, Ishikawa K. Lisinopril reduces left ventricular hypertrophy and cardiac polyamine concentrations without a reduction in left ventricular wall stress in transgenic Tsukuba hypertensive mice. Hypertens Res. 2000 Nov;23(6):625-31. |
| 11 | Kanamasa K, Naito N, Morii H, Nakano K, Tanaka Y, Kitayama K, Haku R, Kai T, Yonekawa O, Nagatani Y, Ishikawa K; Secondary Prevention Group. Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction. Hypertens Res. 2004 Aug;27(8):563-72. |
| 12 | Kai T, Arima S, Taniyama Y, Nakabou M, Kanamasa K. Comparison of the effect of lipophilic and hydrophilic statins on serum adiponectin levels in patients with mild hypertension and dyslipidemia: Kinki Adiponectin Interventional (KAI) Study. Clin Exp Hypertens. 2008 Oct;30(7):530-40. |
| 13 | Kai T, Kanamasa K. Effects of increasing the dose of pravastatin on serum adiponectin level in Japanese mild hypercholesterolemic and hypertensive patients. Arzneimittelforschung. 2009;59(9):445-50. |
| 14 | Kai T, Kuzumoto Y. Effects of a dual L/N-type calcium channel blocker cilnidipine on blood pressure, pulse rate, and autonomic functions in patients with mild to moderate hypertension. Clin Exp Hypertens. 2009 Oct;31(7):595-604. |
| 15 | Nakabou M, Kai T, Maeshima T, Kanamasa K. Hypertensive encephalopathy in patients with chronic renal failure caused by stopping antihypertensive agents: a report of two cases. Clin Exp Nephrol. 2010 Jun;14(3):256-62. |
| 16 | Umakoshi H, Wada N, Ichijo T, Kamemura K, Matsuda Y, Fuji Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Tsuiki M, Naruse M; WAVES-J Study Group. Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism. Clin Endocrinol (Oxf). 2015 Dec;83(6):768-73. |
| 17 | Umakoshi H, Naruse M, Wada N, Ichijo T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Nanba K, Tsuiki M; WAVES-J Study Group. Adrenal Venous Sampling in Patients With Positive Screening but Negative Confirmatory Testing for Primary Aldosteronism. Hypertension. 2016 May;67(5):1014-9. |
| 18 | Shibayama Y, Wada N, Umakoshi H, Ichijo T, Fujii Y, Kamemura K, Kai T, Sakamoto R, Ogo A, Matsuda Y, Fukuoka T, Tsuiki M, Suzuki T, Naruse M. Bilateral aldosterone suppression and its resolution in adrenal vein sampling of patients with primary aldosteronism: Analysis of data from the WAVES-J study. Clin Endocrinol (Oxf). 2016 Nov;85(5):696-702. |
| 19 | Wada N, Shibayama Y, Umakoshi H, Ichijo T, Fujii Y, Kamemura K, Kai T, Sakamoto R, Ogo A, Matsuda Y, Fukuoka T, Tsuiki M, Suzuki T, Naruse M. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism: Data analysis of the WAVES-J study. J Hum Hypertens. 2017 Oct;31(10):627-632. |
| 20 | Fujii Y, Umakoshi H, Wada N, Ichijo T, Kamemura K, Matsuda Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Nanba K, Tsuiki M, Naruse M; WAVES-J Study Group. Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling. J Hum Hypertens. 2017 Dec;32(1):12-19 |
| 21 | Umakoshi H, Xiaomei Y, Ichijo T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Ogasawara T, Tsuiki M, Naruse M; WAVES-J Study Group. Reassessment of the cosyntropin stimulation test in the confirmatory diagnosis and subtype classification of primary aldosteronism. Clin Endocrinol (Oxf). 2017 Feb;86(2):170-176. |
| 22 | Kamemura K, Wada N, Ichijo T, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Umakoshi H, Tsuiki M, Naruse M. Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism. J Hum Hypertens. 2017 Mar;31(3):195-199. |
| 23 | Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yanase T, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M. Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism. J Endocr Soc. 2018 May 24;2(8):893-902. |
| 24 | Akehi Y, Yanase T, Motonaga R, Umakoshi H, Tsuiki M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M; Japan Primary Aldosteronism Study Group. High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan. Diabetes Care. 2019 May;42(5):938-945. |
| 25 | Ohno Y, Sone M, Inagaki N, Takeda Y, Kurihara I, Tsuiki M, Ichijo T, Wada N, Katabami T, Ogawa Y, Okamura S, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Chiba Y, Naruse M; JPAS/JRAS Study Group. Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4382-4389. |
| 26 | Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M. Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism. Eur J Endocrinol. 2019 Sep;181(3):339-350. |
| 27 | Fujii Y, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Yamamoto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T, Umakoshi H, Ogasawara T, Tsiki M, Mitsuhide N, Yamada M, Rakugi H, Kawamura T, Ogawa O, Tanabe A, Hasegawa T, Abe M, Sakamoto R, Shinbo T, Kai T, Fukuoka T, Murakami M, Hashimoto S, Tanabe M, Kometani M, Yoshikawa Y, Oono Y, Fukuda H, Yoneda T, Sugiyama T, Matsuda F, Yamasaki T, Kawaguchi T. Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan. J Hum Hypertens 2020 Jan;34(1):34-42 |
| 28 | Nishimoto K, Umakoshi H, Seki T, Yasuda M, Araki R, Otsuki M, Katabami T, Shibata H, Ogawa Y, Wada N, Sone M, Okamura S, Izawa S, Miyauchi S, Yoshimoto T, Tsuiki M, Naruse M, Fukuda H, Tanaka Y, Takeda Y, Kurihara I, Itoh H, Ichijo T, Shibayama Y, Kawashima J, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Rakugi H, Yamamoto K, Ogo A, Miyauchi S, Yanase T, Suzuki T, Kawamura T, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Sakamoto R, Chiba Y. Diverse pathological lesions of primary aldosteronism and their clinical significance. Hypertens Res. 2021 May;44(5):498-507 |
| 29 | Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Oki K, Inagaki N, Okamura S, Kai T, Izawa S, Yamada M, Chiba Y, Tanabe A, Naruse M. Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism. Atherosclerosis 2021 May;324(5):84-90 |
| 30 | Nakamura R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Watanabe M, Kamemura K, Okamura S, Tanabe A, Naruse M, Itoh H, Fukuda H, Umakoshi H, Shibayama Y, Murakami M, Yoshimoto T, Haze T, Sone M, Takahashi K, Matsuda Y, Shibata H, Otsuki M, Fujii Y, Ogo A, Miyauchi S, Yanase T, Suzuki T, Kawamura T, Asano M, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Sakamoto R, Chiba Y, Okamoto R, Oki K, Yabe D. Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism. Sci Rep 2021; 11: 6925 |
| 31 | Haze T, Yano Y, Hatano Y, Tamura K, Kurihara I, Kobayashi I, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Okamura K, Kai T, Izawa S, Yoshikawa Y, Yamada M, Chiba Y, Tanabe A, Naruse M. Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function. J Hum Hypertens 2022 Oct; 36(10):904-910 |
072-366-1366
電話
